Search

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.

Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.

Sloan Kettering Institute investigators have learned how Hedgehog proteins, which are important in both development and cancer, are assembled.

Siting Gan has the heart of a rebel. Although she focused on physics in high school in Beijing, China, where she grew up, and chose to major in physics in college, she knew that she “wanted to do research and discover things myself.” That determination to pursue her own questions led her to biology and, ultimately, to a unique situation at Sloan Kettering Institute (SKI).

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.

Since 2019, the Robbins Family Foundation has sponsored awards to honor MSK nurses’ extraordinary achievements and contributions to MSK’s mission and core values.

Memorial Sloan Kettering established The Nonna's Garden Foundation Initiative for Cancer Care and Research and recently renamed its first freestanding regional location on Long Island, following a generous $50 million gift from Mike and Maria Repole and the Nonna's Garden Foundation.